Clinical Trial Update: Study of the Combination of Axitinib Plus Everolimus in Patients With Malignant Advanced Solid Tumors [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating the combination of axitinib and everolimus in patients with malignant advanced solid tumors, including renal cell carcinoma, has comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• Afinitor (everolimus)
• INLYTA (AXITINIB)

Snippet

Sponsor: University Hospital, Bordeaux | Conditions: Malignant Advanced Solid Tumors, Carcinoma, Renal Cell | Phase 1 | Status: COMPLETED